Evidence map›Paper›PMID 30477370›Full record

ArticleThe Journal of international medical research2019

Onset of menarche is not delayed in Slovenian patients with celiac disease.

Dušanka Mičetić-Turk, Veljko Vlaisavljević, Eva Turk, Maja Šikić Pogačar

Open access · goldAbstract read
In one paragraph

Article in The Journal of international medical research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Dušanka Mičetić-Turk1 Department of Pediatrics, Faculty of Medicine, University of Maribor, Maribor, Slovenia.
Veljko Vlaisavljević2 IVF Adria Consulting, Maribor, Slovenia.
Eva Turk1 Department of Pediatrics, Faculty of Medicine, University of Maribor, Maribor, Slovenia.
Maja Šikić Pogačar1 Department of Pediatrics, Faculty of Medicine, University of Maribor, Maribor, Slovenia.
University of Maribor · SI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveCeliac disease (CD) is an autoimmune disorder associated with numerous health problems, including reproductive disorders. This study was performed to analyze the association between CD and the menstrual cycle in a group of patients with CD and compare these patients' characteristics with those of healthy women.

methodsThe study included 145 patients with CD (age, 15-51 years) and 162 healthy women (age, 18-55 years). Age at menarche and characteristics of the menstrual cycle were obtained by an anonymous questionnaire developed for the study.

resultsThe age at onset of menarche was 12 to 14 years in 72.9% of the patients with CD and 77.3% of the healthy controls. For most patients (74.2%), the length of the menstrual cycle was around 27 to 28 days with 4 to 5 days of bleeding. Furthermore, 8.4% of patients versus 5.9% of controls experienced bleeding between cycles.

conclusionsOur results suggest that in Slovenia, the age at menarche in patients with CD is 12.7 years, which is comparable with that in healthy women. We conclude that CD (treated or untreated) may not be associated with late menarche.

Indexed as

MenarcheAdolescentAdultAge FactorsAge of OnsetCase-Control StudiesCeliac DiseaseChildFemaleFollow-Up StudiesHumansMaleMiddle AgedPrognosisSloveniaYoung AdultCeliac diseasechildren and adolescentsmenarche agemenstrual disordersquestionnaireSlovenia

Identifiers

PMID30477370
PMCPMC6381496
OpenAlexW2902380203

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.